Detalhe da pesquisa
1.
Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008-2018: The EACH-WOMAN Project.
J Low Genit Tract Dis
; 27(2): 105-112, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815642
2.
Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors' reply.
Lancet
; 398(10313): 1801-1802, 2021 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774142
3.
Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis.
Lancet
; 398(10300): 577-578, 2021 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329583
4.
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies.
Infect Dis Ther
; 13(1): 173-187, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38221576
5.
Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.
Sci Rep
; 12(1): 7961, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562373
6.
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Vaccine
; 40(38): 5585-5593, 2022 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989136
7.
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months.
J Clin Invest
; 132(18)2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106642
8.
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Hum Vaccin
; 7(12): 1336-42, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22185811
9.
Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
Hum Vaccin Immunother
; 17(5): 1288-1293, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175656
10.
Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population.
Hum Vaccin Immunother
; 16(6): 1404-1412, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860383
11.
Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults.
Hum Vaccin
; 5(2): 92-7, 2009 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-18690015
12.
Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination.
Lancet Glob Health
; 10(1): e33-e34, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919849
13.
Repurposing historical control clinical trial data to provide safety context.
Drug Discov Today
; 21(2): 212-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26523771
14.
Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.
Pediatr Infect Dis J
; 35(5): 548-54, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26835974
15.
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.
Vaccine
; 34(6): 809-13, 2016 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26707218
16.
A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents.
Pediatr Infect Dis J
; 35(6): 673-82, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26974889
17.
Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Vaccine
; 32(48): 6521-6, 2014 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25252192
18.
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Pediatr Infect Dis J
; 33(1): 73-80, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24346596
19.
Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study.
Pediatr Infect Dis J
; 32(1): 54-61, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23241989
20.
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
Vaccine
; 30(8): 1476-80, 2012 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22227229